This action was associated with reduced invasiveness of human glioma cells [144], suggesting metformin may suppress tumour progression at least in part by inhibiting the ECM remodelling that underlies a metastasis-conducive tumour micro-environment through regulation of fibulin-3 expression. Here, EFEMP1 is linked to glioma.